Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Louisa Bolm is a leading surgical oncologist whose research centers on advancing minimally invasive techniques in pancreatic and hepatobiliary surgery. Her major contributions lie in rigorously comparing surgical outcomes across laparoscopic, robotic, and open approaches for complex malignancies. In her landmark 2022 study on distal cholangiocarcinoma (26 citations), she demonstrated that minimally invasive pancreatoduodenectomy can achieve comparable oncological outcomes to open surgery, challenging long-held clinical conventions. Her pan-European multicenter propensity-matched study (2024, 20 citations) provided crucial evidence that robot-assisted pancreatoduodenectomy offers distinct advantages over laparoscopic approaches, including improved lymph node retrieval and reduced conversion rates. Dr. Bolm has also shaped global surgical policy through her comprehensive reviews on minimally invasive pancreatic cancer surgery (2023, 7 citations) and her visionary work on strategies for diffusing robotic surgery worldwide (2025, 4 citations). Her international multicenter cohort study on ampullary adenocarcinoma (2024, 3 citations) further solidifies her reputation as a methodologically rigorous investigator. Through her high-impact comparative effectiveness research, Dr. Bolm is helping define the optimal surgical pathways for patients with pancreatic and periampullary cancers.